Gingival fibromatosis with hemi-osseous hyperplasia of jaws, focal maxillary viral papillomatosis of gingiva, fissured tongue and congenitally missing anterior teeth: a case report and surgical management of a new syndrome

Gingival fibromatosis is characterized by fibrotic enlargement of the gingiva that can occur as inherited or sporadic form. Inherited form can be an isolated trait or as a component of a syndrome. This article reports a 35 year old male patient affected by gingival fibromatosis associated with hemiosseous hyperplasia of mandible, maxilla, and zygoma on the right side, viral papillomatosis of maxillary anterior gingiva, fissured tongue and congenitally missing anterior teeth. The patient was subjected to phase I and phase II periodontal therapy. There was no evidence of recurrence of the enlargement after one year but the papillomatosis recurred. Gingival fibromatosis has been reported to be associated with various other abnormalities but not with those described in our case. This observation raises the possibility that the coexistence of these entities in our case may represent a new syndrome.

Studies on the Preparation and Evaluation of Chitosan Nanoparticles containing Cytarabine

The activity of cytarabine was decreased by its rapid deamination to the biologically inactive metabolite uracil arabinoside. This rapid deamination is the reason for the ongoing research for effective formulation of cytarabine that can not be deaminated and exhibit better pharmacokinetic parameters. Protection of cytarabine from fast degradation and elimination was investigated by encapsulating the drug into chitosan nanoparticles. Cytarabine loaded nanoparticles prepared by ionotropic gelation were characterized by SEM and was found to in the range of 200 nm.The mechanism by which drug is being released is non-Fickian(anomalous) solute diffusion mechanism. It is evident from the result that initial burst release was retarded or delayed due to adsorption of coating material. The in vivo biodistribution study results showed that the nanoparticles were having better distribution of drug compared to free drug in different organs like spleen, lungs, kidney etc.